VAERS 1320124
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN8207
- Staat
- SC
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 15.05.2021
- Impfdatum
- 01.04.2021
- Beginn
- 07.04.2021
- Tage bis Beginn
- 6,0
- Dosis
- 2
- Route/Site
- - / LA
Symptomtext
Developed Deep Vein Thrombosis. Diagnosed 30Apr2021; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 01Apr2021 14:30 (Batch/lot number: EN8207) as 2nd dose, single for COVID-19 immunisation. Medical history included Diabetes, High Blood Pressure and High Cholesterol, all from an unknown date. There no concomitant medications. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) in Arm Left on 11Mar2021 11:45 AM (Batch/lot number: EP7533) at the age of 59-year-old for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient developed deep vein thrombosis since 07Apr2021, which was diagnosed on 30Apr2021. Therapeutic measures were taken as a result of deep vein thrombosis which included Prescribed Xarelto. The adverse event result in Doctor or other healthcare professional office/clinic visit. The outcome of event was not recovered. Since the vaccination, the patient has not been tested for COVID-19.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Blood pressure high; Diabetes; High cholesterol
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -